Output | Condition 1 | Condition 2 | Condition 3 | Covering |
---|---|---|---|---|
GDS4968 | ||||
Monoc. Gamm. | SNHG3_1 ≤ 9.28 | SNORA14B ≤ 4.30 | – | 95.0% |
Monoc. Gamm. | Control_3389 ≤ 8.20 | – | – | 60.0% |
MM | THOP1 > 6.23 | TARP_5 ≤ 6.71 | – | 85.4% |
MM | C22orf23 ≤ 5.20 | FLJ20712 ≤ 3.14 | – | 26.8% |
Smold. MM | DNAJC7 > 8.13 | IGK_2 ≤ 10.4561 | DEK > 6.50 | 97.0% |
Smold. MM | HNRNPA1 > 6.44 | – | – | 51.5% |
GDS4887 | ||||
HC | AQP7 ≤ 8.46 | – | – | 100% |
Non tumor | CLPX_1 > 11.4116 | – | – | 100% |
GDS4794 | ||||
Normal cells | DSCC1_1 ≤ 110.1 | – | – | 100% |
SCLC | CBX3_1 > 2232.75 | – | – | 100% |
GDS4762 | ||||
Breast cancer | FMN2 < = 116.32 | – | – | 100% |
Fibroblast | SHC4 > 52.20 | – | – | 100% |
GDS4471 | ||||
Classic MB | EFHD2_1 > 3.87 | LOC100132891 ≤ 4.37 | – | 88.3% |
Classic MB | TCL1A > 4.66 | – | – | 31.4% |
Other MB | LOC100132891 > 4.18 | 5.47 < ZMYM5_3 ≤ 6.17 | 76.0% | |
Other MB | CHIAP2 > 3.38 | ZNF212 ≤ 6.45 | – | 40.0% |
GDS4296 | ||||
Colon cancer | KLK6 > 7.71 | – | – | 100% |
Melanoma | EDNRB > 5.72279 | – | – | 100% |
Non-SCLC | 5.61 < TMEM51 ≤ 6.55 | FAM177A1 > 8.27 | LINC00936 > 5.59 | 100% |
Ovarian cancer | TMEM101 ≤ 6.15 | – | – | 85% |
Ovarian cancer | MEIS1_1 > 6.70 | – | – | 57.1% |
Renal cancer | LRRN4 > 4.69 | APBB1IP_2 > 7.46 | – | 100% |
GDS3952 | ||||
Benign diseasea | 2.32 < IGHV7–81 ≤ 3.29 | 2.87 < BM983749 ≤ 4.06 | LIM2 > 4.11 | 83.8% |
Benign diseasea | LCP2_1 > 9.07 | ST8SIA2_1 ≤ 2.215 | – | 27.0% |
Ectopic cancers | ST3GAL1 > 6.55 | PWWP2A > 6.18 | – | 100% |
Healthy controls | USMG5 > 11.85 | – | – | 90.3% |
Healthy controls | NUFIP2_1 > 8.81 | – | – | 41.9% |
Breast cancera | MKNK1 ≤ 3.91 | 227762_at ≤8.3 | BF194770 > 2.385 | 80.4% |
Breast cancer | ZNF81 ≤ 2.99 | MMAB_1 ≤ 4.095 | – | 29.4% |
Breast cancer | AU143882 > 4.57 | – | – | 21.6% |
GDS3945 | ||||
Untreated controls | COQ10A < = 125.66 | – | – | 100% |
Renal cancer | COQ10A > 125.66 | – | – | 100% |